- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07665008
MULTİDİMENSİONAL ASSESSMENT OF MUSCLE FATİGUE İN SOCCER PLAYERS (MAMF)
MULTIDIMENSIONAL ASSESSMENT OF MUSCLE FATIGUE USING ACCELEROMETER, ELECTROMYOGRAPHY AND MUSCLE THICKNESS DATA
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Muscle fatigue is commonly assessed using surface electromyography (sEMG), particularly through frequency-domain parameters such as median frequency. However, fatigue-related changes are not limited to electrical activity and may also involve alterations in muscle mechanical behavior and morphological characteristics. Accelerometer-derived signals provide information regarding muscle vibrations and mechanical oscillations, while ultrasonographic measurements of muscle thickness provide information about muscle morphology and force-generating capacity.
The purpose of this study was to examine the relationships among muscle thickness, sEMG median frequency, accelerometer-derived mechanical vibration parameters, and isometric force variables during maximal voluntary isometric contractions performed at different knee flexion angles. Healthy male soccer players participated in a laboratory-based assessment protocol including ultrasonography, synchronized sEMG recordings, triaxial accelerometry, and isokinetic dynamometry.
Muscle thickness of the vastus lateralis obliquus (VLO), vastus medialis obliquus (VMO), and rectus femoris obliquus (RFO) muscles was measured using ultrasonography. Participants subsequently performed maximal voluntary isometric contractions at 90°, 60°, and 30° knee flexion angles. Surface electromyography, accelerometer signals, and force-related variables were recorded simultaneously. Median frequency values, acceleration-based root mean square (RMS) parameters, peak torque, mean torque, and time-to-peak torque variables were analyzed.
The study aimed to provide a multidimensional framework for muscle fatigue assessment by integrating morphological, electrical, and mechanical indicators and to explore their associations in healthy athletic populations.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Merkez
-
Ordu, Merkez, Tyrkia (Türkiye), 52100
- Ordu University Faculty of Sports Sciences
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Healthy male soccer players aged 18-30 years
- No lower extremity injury within the previous six months
- No condition limiting lower extremity exercise performance
- No caffeine or stimulant consumption on the testing day
- Non-smoker
- Provided written informed consent
Exclusion Criteria:
- Female athletes
- Serious injury to the dominant leg within the previous year
- Intense exercise within the previous 24 hours
- Use of pain relievers or muscle relaxants on the testing day
- Inability to complete testing procedures
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Healthy Male Soccer Players
Healthy male soccer players aged 18-30 years who participated in a cross-sectional observational study.
Participants underwent ultrasonographic muscle thickness assessment, surface electromyography (sEMG), accelerometer-based mechanical vibration measurements, and isometric strength testing during maximal voluntary isometric contractions performed at different knee flexion angles (30°, 60°, and 90°).
|
Participants underwent non-invasive neuromuscular assessment procedures using surface electromyography (sEMG), triaxial accelerometers, ultrasonography, and an isokinetic dynamometer.
Measurements were performed during maximal voluntary isometric contractions at 30°, 60°, and 90° knee flexion angles.
The devices were used exclusively for data collection and assessment purposes.
No therapeutic, pharmacological, behavioral, or rehabilitative intervention was administered.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Surface Electromyography (sEMG) Median Frequency
Tidsramme: Day 1
|
Median frequency (Hz) obtained from the vastus lateralis obliquus (VLO), vastus medialis obliquus (VMO), and rectus femoris obliquus (RFO) muscles during maximal voluntary isometric contractions performed at 30°, 60°, and 90° knee flexion angles.
|
Day 1
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Muscle Thickness
Tidsramme: Day 1
|
Ultrasonographic muscle thickness measurements of the VLO, VMO, and RFO muscles (mm).
|
Day 1
|
|
Accelerometer-Derived Mechanical Vibration Parameters
Tidsramme: Day 1
|
Root mean square (RMS) acceleration values obtained from thigh and shank triaxial accelerometers during isometric contractions.
|
Day 1
|
|
Isometric Strength Parameters
Tidsramme: Day 1
|
Peak torque, mean torque, and time-to-peak torque measured using an isokinetic dynamometer during maximal voluntary isometric contractions.
|
Day 1
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Tuğçe Namazcı, PhD, Giresun Üniversitesi
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- TN-2024-127
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .